Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 266 | 2019 |
Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus FK Keating, BE Sobel, DJ Schneider The American journal of cardiology 92 (11), 1362-1365, 2003 | 224 | 2003 |
Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients with acute ST-elevation myocardial infarction KH Scholz, R Hilgers, D Ahlersmann, H Duwald, R Nitsche, ... The American journal of cardiology 101 (1), 46-52, 2008 | 91 | 2008 |
Pharmacodynamic effects during the transition between cangrelor and ticagrelor DJ Schneider, Z Agarwal, N Seecheran, FK Keating, P Gogo JACC: Cardiovascular Interventions 7 (4), 435-442, 2014 | 83 | 2014 |
Pharmacodynamic effects during the transition between cangrelor and prasugrel DJ Schneider, N Seecheran, SS Raza, FK Keating, P Gogo Coronary Artery Disease 26 (1), 42-48, 2015 | 73 | 2015 |
Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of ST-segment elevation myocardial infarction KH Scholz, SKG Maier, J Jung, C Fleischmann, GS Werner, HG Olbrich, ... JACC: Cardiovascular Interventions 5 (8), 848-857, 2012 | 67 | 2012 |
Increased expression of platelet P-selectin and formation of platelet–leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared … FK Keating, HL Dauerman, DA Whitaker, BE Sobel, DJ Schneider Thrombosis research 118 (3), 361-369, 2006 | 63 | 2006 |
Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis FK Keating, DA Whitaker, SS Kabbani, MA Ricci, BE Sobel, DJ Schneider The American journal of cardiology 94 (6), 725-728, 2004 | 57 | 2004 |
Platelet‐white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells FK Keating, S Butenas, MK Fung, DJ Schneider Transfusion 51 (5), 1086-1095, 2011 | 54 | 2011 |
Greater inhibitory effects of bivalirudin compared with unfractionated heparin plus eptifibitide on thrombin-induced platelet activation DJ Schneider, F Keating, BE Sobel Coronary artery disease 17 (5), 471-476, 2006 | 30 | 2006 |
Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 27 | 2021 |
Effect of exercise training and weight loss on platelet reactivity in overweight patients with coronary artery disease FK Keating, DJ Schneider, PD Savage, JY Bunn, J Harvey-Berino, ... Journal of cardiopulmonary rehabilitation and prevention 33 (6), 371-377, 2013 | 27 | 2013 |
Program directors survey on diversity in cardiovascular training programs JB Damp, MW Cullen, V Soukoulis, MC Tam, FK Keating, SA Smith, ... Journal of the American College of Cardiology 76 (10), 1215-1222, 2020 | 23 | 2020 |
Optimizing Systems of Care for Patients with Acute Myocardial Infarction. STEMI Networks, Telemetry ECG, and Standardized Quality Improvement with Systematic Data Feedback … KH Scholz, G von Knobelsdorff, D Ahlersmann, FK Keating, J Jung, ... Herz Kardiovaskuläre Erkrankungen 33, 102-109, 2008 | 22 | 2008 |
The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention FK Keating, HL Dauerman, DA Whitaker, BE Sobel, DJ Schneider Coronary artery disease 16 (6), 401-405, 2005 | 20 | 2005 |
Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes FK Keating, DA Whitaker, BE Sobel, DJ Schneider Thrombosis research 113 (1), 27-34, 2004 | 20 | 2004 |
Thrombosis risk in cancer patients receiving red blood cell transfusions G Ramsey, PF Lindholm Seminars in thrombosis and hemostasis 45 (06), 648-656, 2019 | 18 | 2019 |
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial JL Carson, MM Brooks, BR Chaitman, JH Alexander, SG Goodman, ... American heart journal 257, 120-129, 2023 | 17 | 2023 |
Procoagulant activity in stored units of red blood cells M Aleshnick, JH Foley, FK Keating, S Butenas Biochemical and Biophysical Research Communications 474 (4), 680-685, 2016 | 16 | 2016 |
Induction of platelet white blood cell (WBC) aggregate formation by platelets and WBCs in red blood cell units FK Keating, MK Fung, DJ Schneider Transfusion 48 (6), 1099-1105, 2008 | 16 | 2008 |